Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Ann Oncol 2018; 29: 127–132 (doi: 10.1093/annonc/mdx529)

https://ift.tt/2HJYnW9